Spectrum Pharmaceuticals, Inc. (SPPI)
$4.67
-0.02 (-0.43%)
| CAPS Rating |
|
|---|---|
| Open | $4.68 |
| Previous Close | $4.69 |
| Daily Range | $4.61 - $4.74 |
| 52-Week Range | $1.21 - $10.00 |
| Market Cap | $195.77M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 784,874 |
| Average Daily Volume | 2,634,000 |
SPPI
VS S&P 500 (SPY)
How do you think SPPI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SPPI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SPPI News and Commentary
- HEADLINE STOCKS-U.S. small/midcap stocks to watch on Nov 3 – Reuters
- UPDATE 1-Spectrum says CMS OKs reimbursement of its cancer drug – Reuters
- 2 Stocks Hitting High Notes – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- 5 Top Stocks at Half Price – The Motley Fool
- Big Investors Can't Touch This Small-Investor Edge – The Motley Fool
- UPDATE 2-Spectrum says FDA refuses to OK new plea on cancer drug – Reuters
- UPDATE 1-Spectrum says FDA refuses to OK new plea on cancer drug – Reuters
- Spectrum gets FDA response letter on cancer drug – Reuters
- Bio-rhythms. – Blog at The Motley Fool
- 5 Stocks Approaching Greatness – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- QUICK, sell the NEWS........ oops, TOO LATE – Blog at The Motley Fool
- UPDATE 1-Spectrum gets FDA nod for expanded use of cancer drug – Reuters
- Top-Rated Stocks That Treat Shareholders Right – The Motley Fool
- Tomorrow's Monster Stock? – The Motley Fool
- These Stocks Can Easily Double Your Money – The Motley Fool
- 4 Stocks Attracting Top Investors – The Motley Fool
- A 1-in-100 Investor – The Motley Fool
- Spectrum Phamaceuticals, Inc. Awating FDA decision - Zevalin milestone payments – Blog at The Motley Fool
RSS Headlines
Fool UK
